predicting patient response to btk inhibitors using novel approaches
Published 1 year ago • 195 plays • Length 1:14Download video MP4
Download video MP3
Similar videos
-
0:52
rilzabrutinib: a novel promising btk inhibitor being explored in itp
-
1:14
evaluating the role of btk inhibitors in cll
-
2:48
the novel icaht grading system to predict toxicity following car t-cell therapy
-
1:05
using machine learning to predict the outcomes of patients with ndmm being treated with vrd
-
1:56
approaching treatment selection and sequencing with the recent influx of btk inhibitors in cll
-
2:25
outcomes & healthcare utilization cost of patients with cll refractory to btk and bcl-2 inhibitors
-
1:52
single-cell and immune sequencing to predict response and resistance to car-t therapy in r/r mm
-
1:59
reducing the side effects associated with btk inhibitors
-
2:01
predict response to immune checkpoint inhibition in acute myeloid leukemia (aml) using biomarkers
-
3:17
pet imaging to predict treatment outcomes: follow-up from the echelon-2 trial
-
4:58
overview of the toxicities associated with bispecific agents in multiple myeloma
-
0:52
novel strategies to evaluate biomarkers of interest in multiple myeloma
-
1:20
improving outcomes of non-covalent btki treatment
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
2:52
acquired mutations associated with resistance to btki in patients with cll
-
0:59
mitigating cardiological toxicities associated with btki in b-cell malignancies
-
2:44
do biomarkers exist for predicting response to car t-cell therapy?
-
1:26
next-generation diagnostic and prognostic approaches in multiple myeloma